A detailed history of L2 Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, L2 Asset Management, LLC holds 14,488 shares of ABBV stock, worth $2.47 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
14,488
Previous 12,552 15.42%
Holding current value
$2.47 Million
Previous $2.15 Million 32.95%
% of portfolio
0.8%
Previous 0.66%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $317,194 - $385,902
1,936 Added 15.42%
14,488 $2.86 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $916,047 - $1.07 Million
5,918 Added 89.21%
12,552 $2.15 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $270,415 - $308,113
1,692 Added 34.24%
6,634 $1.21 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $629,657 - $709,142
4,576 Added 1250.27%
4,942 $765,000
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $1.56 Million - $1.8 Million
-11,650 Reduced 96.95%
366 $54,000
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $221,689 - $275,877
1,673 Added 16.18%
12,016 $1.62 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $168,181 - $193,686
-1,163 Reduced 10.11%
10,343 $1.65 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $54,623 - $62,649
407 Added 3.67%
11,506 $1.54 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $223,357 - $283,960
1,623 Added 17.13%
11,099 $1.7 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $556,031 - $689,878
4,213 Added 80.05%
9,476 $1.54 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $134,717 - $170,456
1,254 Added 31.28%
5,263 $713,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $102,144 - $115,948
-960 Reduced 19.32%
4,009 $432,000
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $128,040 - $142,644
-1,217 Reduced 19.67%
4,969 $560,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $523,878 - $576,727
-5,121 Reduced 45.29%
6,186 $669,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $186,173 - $251,353
-2,313 Reduced 16.98%
11,307 $1.21 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $1.1 Million - $1.29 Million
-12,812 Reduced 48.47%
13,620 $1.19 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $56,054 - $75,009
764 Added 2.98%
26,432 $2.6 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $465,883 - $706,337
7,223 Added 39.16%
25,668 $1.96 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $1.33 Million - $1.66 Million
18,445 New
18,445 $1.63 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track L2 Asset Management, LLC Portfolio

Follow L2 Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on L2 Asset Management, LLC with notifications on news.